Association of peripheral blood pressure with gray matter volume in 19- to 40-year-old adults.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
19 02 2019
Historique:
received: 09 01 2018
accepted: 15 10 2018
pubmed: 25 1 2019
medline: 26 11 2019
entrez: 25 1 2019
Statut: ppublish

Résumé

To test whether elevated blood pressure (BP) relates to gray matter (GM) volume (GMV) changes in young adults who had not previously been diagnosed with hypertension (systolic BP [SBP]/diastolic BP [DBP] ≥140/90 mm Hg). We associated BP with GMV from structural 3T T1-weighted MRI of 423 healthy adults between 19 and 40 years of age (mean age 27.7 ± 5.3 years, 177 women, SBP/DBP 123.2/73.4 ± 12.2/8.5 mm Hg). Data originated from 4 previously unpublished cross-sectional studies conducted in Leipzig, Germany. We performed voxel-based morphometry on each study separately and combined results in image-based meta-analyses (IBMA) to assess cumulative effects across studies. Resting BP was assigned to 1 of 4 categories: (1) SBP <120 and DBP <80 mm Hg, (2) SBP 120-129 or DBP 80-84 mm Hg, (3) SBP 130-139 or DBP 85-89 mm Hg, (4) SBP ≥140 or DBP ≥90 mm Hg. IBMA yielded the following results: (1) lower regional GMV was correlated with higher peripheral BP; (2) lower GMV was found with higher BP when comparing individuals in subhypertensive categories 3 and 2, respectively, to those in category 1; (3) lower BP-related GMV was found in regions including hippocampus, amygdala, thalamus, frontal, and parietal structures (e.g., precuneus). BP ≥120/80 mm Hg was associated with lower GMV in regions that have previously been related to GM decline in older individuals with manifest hypertension. Our study shows that BP-associated GM alterations emerge continuously across the range of BP and earlier in adulthood than previously assumed. This suggests that treating hypertension or maintaining lower BP in early adulthood might be essential for preventing the pathophysiologic cascade of asymptomatic cerebrovascular disease to symptomatic end-organ damage, such as stroke or dementia.

Identifiants

pubmed: 30674602
pii: WNL.0000000000006947
doi: 10.1212/WNL.0000000000006947
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e758-e773

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 American Academy of Neurology.

Auteurs

H Lina Schaare (HL)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany. schaare@cbs.mpg.de.

Shahrzad Kharabian Masouleh (S)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Frauke Beyer (F)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Deniz Kumral (D)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Marie Uhlig (M)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Janis D Reinelt (JD)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Andrea M F Reiter (AMF)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Leonie Lampe (L)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Anahit Babayan (A)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Miray Erbey (M)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Josefin Roebbig (J)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Matthias L Schroeter (ML)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Hadas Okon-Singer (H)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Karsten Müller (K)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Natacha Mendes (N)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Daniel S Margulies (DS)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

A Veronica Witte (AV)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Michael Gaebler (M)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Arno Villringer (A)

From the Department of Neurology (H.L.S., S.K.M., F.B., D.K., M.U., J.D.R., A.M.F.R., L.L., A.B., M.E., J.R., M.L.S., A.V.W., M.G., A.V.), Max Planck Research Group for Neuroanatomy & Connectivity (N.M., D.S.M.), and Nuclear Magnetic Resonance Group (K.M.), Max Planck Institute for Human Cognitive and Brain Sciences; International Max Planck Research School NeuroCom (H.L.S., M.U.), Leipzig; MindBrainBody Institute at Berlin School of Mind and Brain (D.K., A.B., M.E., M.G., A.V.), Charité & Humboldt Universität zu Berlin; Lifespan Developmental Neuroscience (A.M.F.R.), Technische Universität Dresden; Leipzig Research Centre for Civilization Diseases (LIFE) (M.L.S., M.G., A.V.), Clinic for Cognitive Neurology (M.L.S., A.V.), and Collaborative Research Centre 1052 'Obesity Mechanisms,' Subproject A1, Faculty of Medicine (F.B., A.V.W., A.V.), University of Leipzig, Germany; Department of Psychology (H.O.-S.), University of Haifa, Israel; and Center for Stroke Research Berlin (A.V.), Charité-Universitätsmedizin Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH